Join us June 1, 2017 for our new RARE Webinar, Make Sense of Your Dollars. If you cannot attend the webinar at its designated time, be sure to register anyways! You will be sent the recorded version when it becomes available online.
Living with a rare disease or having a loved one with a rare disease is something no one plans on and it can, unfortunately, create financial burdens. With the right guidance in financial planning, you can overcome these financial obstacles. Listen in to hear professionals in finance guide you through financial planning and preparation.
If you are unable to attend the live webinar, still register so you can receive a link to the recorded content.
Don’t forget, to access this webinar use the password: “Rare” with a capital “R”
Panelists:
Lori Leathers, Advisor, 1847 Financial
As an advisor with 1847Financial, Lori supports the goals of individuals and families through life insurance, fixed annuities, disability, and long-‐term care insurance. Before working in this industry, Lori as a pharmaceutical sales representative for Merck&Co., but experienced a life-‐changing event when she became the mother of a son diagnosed with Fragile X Syndrome. Lori made a significant career change to help other families navigate through the special needs planning process, and to help them secure the future they envisioned for themselves and their loved ones. Her mission is to help as many families as possible achieve their goals by ensuring all financial, legal, and government benefit resources effectively combine to work to their advantage.
Lori is involved in many efforts within the special needs community, including advocacy, participation in clinical research, co-‐leader and member of parent support groups, and a parent mentor of Parent to Parent USA. Lori is also a member of Children and Adults with Attention Deficit Disorder (CHADD), and Parent and Founder of the Special Needs Resource Network.
Lori received her Bachelor’s Degree in Biology from Bucknell University and her Master of Science degree in Ecology from Pennsylvania State University. She also obtained a Master of Science degree in Regulatory Affairs and Quality Assurance from Temple University in Philadelphia, PA.
Pat Bergmaier, CFP, ChSNC, Chartered Special Needs Consultant, 1847 Financial
Pat is a Certified Financial Planner (CFP) and has a passion for working with families. His knowledge and expertise allows him to develop comprehensive and holistic financial plans for his clients that provide the framework for making financial decisions that will help achieve their lifetime and legacy planning goals.
Pat is also a Chartered Special Needs Consultant (ChSNC).This designation has provided Pat with the knowledge to address the unique circumstances and requirements of planning for individuals with special needs a core focus of his practice. Pat received his Bachelor’s Degree in Finance from Albright College in Reading, PA and holds his FINRA Series 7, 66, 63 & 6 Securities Licenses. Pat began his career in the financial services industry in 2005 after a successful baseball career at Albright where he was awarded Conference Player of the Year during his senior season.
Prior to joining 1847Financial, Pat partnered with the MetLife Center for Special Needs Planning where his passion for working with the special needs community began. He is a board member of the Timothy School in Berwyn, PA which is devoted exclusively to teaching students with autism. He is involved with supporting many special needs organizations such as Ascend–the Asperger and Autism Alliance of Greater Philadelphia, Autism Cares Foundation, Down Syndrome Interest Groups, and PLAN of PA.
Tony Ferrandino, Founder, Drew’s Hope & Senior Financial Advisor, Merill Lynch
Tony Ferrandino founded Drew’s Hope in 2007 with his wife, Katie, when their son Drew was diagnosed with Batten disease. Drew’s Hope is a non-profit foundation which is focused on raising funds for Batten disease research. As a parent of a child with a rare disease, Tony has used his personal experience to fuel his passion for advocacy. In September of 2014, Drew passed away from late infantile Batten disease. Tony serves on the Board of Directors for the Batten Disease Support and Research Association (BDSRA) and works closely with the Scientific Advisory Board to determine appropriate research funding. He received a Portrait of Courage Award in 2015 from the National Organization for Rare Disorders (NORD) for his continued efforts to raise funds for research. Tony is a Senior Financial Advisor at Merrill Lynch with over 25 years of experience in the financial services industry and he has focused on helping families with special needs children prepare financially for life’s transitions.
Moderator:
Daniel Levine, Founder & Principal, Levine Media Group
Daniel Levine is an award-winning business journalist who has reported on the life sciences, economic development, and business policy issues throughout his 25-year career. Since 2011, he has served as the lead editor and writer of Burrill Media’s acclaimed annual book on the biotech industry and hosts The Burrill Report’s weekly podcast. His work has appeared in The New York Times, The Industry Standard, TheStreet.com, and other national publications.
This RARE Webinar is proudly supported by
Follow us on Twitter
Help Us Reach 170K “Likes”
Image missing or invalid URL. Please check the Image widget URL in your widget settings.
Contact Global Genes
28 Argonaut, Suite 150
Aliso Viejo, CA 92656
(+1) 949-248-RARE (7273)
Global Genes®
Copyright © 2015 Global Genes.
Global Genes is a non-profit 501(c)(3) corporation advocating for rare disease globally. Privacy Policy
Related
FDA approves Pharming’s Joenja for the treatment of APDS
Rare Daily Staff The U.S. Food and Drug Administration has approved Pharming Group’s Joenja for the treatment […]
Read moreNHS Patients with rare genetic disorders to be fast-tracked to earlier diagnosis and specialist care
Rare Daily Staff NHS England said it is launching a new service to fast track diagnosis and […]
Read moreEuropean Commission Approves Amicus’ Pombiliti in Patients with Late-Onset Pompe Disease
Rare Daily Staff The European Commission has granted approval for Amicus Therapeutics’ Pombiliti, a long-term enzyme replacement […]
Read moreIonis and AstraZeneca Report Positive Topline 66-Week Results of Eplontersen Phase 3 Study for Patients with ATTRv-PN
Rare Daily Staff Ionis Pharmaceuticals and AstraZeneca reported positive topline results from the 66-week analysis of the […]
Read moreNICE Recommends PTC’s AADC Gene Therapy
Rare Daily Staff The United Kingdom’s National Institute for Health and Care Excellence, the drug price watchdog, […]
Read morePTC and Innozyme CEOs Each Announce Their Retirement
Rare Daily Staff PTC Therapeutics Founding CEO Stuart Peltz said that he is stepping down after 25 […]
Read more2023 RARE Mental Health Grant Recipients Announced
Global Genes is pleased to announce the Rare Disease Patient Advocacy Organizations receiving 2023 RARE Mental Health […]
Read moreSeeking a Sustainable Business Developing on N-of-1 Therapies
The ability to pinpoint the underlying genetic causes of diseases and rapidly generate genetic medicines to address […]
Read moreGlobal Genes Team Shares Their Stories on World Rare Disease Day
My daughter Juno was diagnosed with a very rare, severe neurodevelopmental condition called STXBP1-related disorder six years […]
Read more